Organon Dirección
Dirección controles de criterios 2/4
El CEO de Organon's es Kevin Ali , nombrado en Jun 2021, tiene una permanencia de 2.83 años. compensación anual total es $14.95M, compuesta por 8.1% salario y 91.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.049% de las acciones de la empresa, por valor de $2.31M. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 2.8 años, respectivamente.
Información clave
Kevin Ali
Chief Executive Officer (CEO)
US$14.8m
Compensación total
| Porcentaje del salario del CEO | 8.4% |
| Permanencia del CEO | 2.9yrs |
| Participación del CEO | 0.05% |
| Permanencia media de la dirección | 2.9yrs |
| Promedio de permanencia en la Junta Directiva | 2.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Four Reasons Why Organon Stock Is A Good Buy
May 07Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings
Apr 21
Organon Stock Is Still Worth A Look
Feb 24Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Feb 19Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
Feb 16Organon: What I'm Looking For In This 8% Yield In 2024
Jan 03High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
Dec 19Organon: It's Darkest Before The Dawn
Nov 30Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace
Nov 07Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28
Nov 05Organon: The Federal Reserve Black Swan (Rating Upgrade)
Oct 046% Yield And Significantly Undervalued: A Closer Look At Organon
Sep 10Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk
Aug 10Organon & Co.: A Tough Spot To Be In Right Now
Jul 16Organon goes ex-dividend tomorrow
Feb 23Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 19Is There Anything Organic Or Interesting About Organon?
Feb 07Organon goes ex-dividend tomorrow
Nov 09Organon's (NYSE:OGN) Dividend Will Be $0.28
Nov 08Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)
Nov 05Organon: Thoughts Ahead Of Q3 Earnings
Oct 31Organon: What Is The Recipe?
Aug 31Oragenics announces early toxicology data for intranasal COVID-19 vaccine
Aug 24Organon, Samsung Bioepis Humira biosimilar Hadlima high concentration dosage gets FDA nod
Aug 17Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Aug 07Organon Q2 2022 Earnings Preview
Aug 03Organon in pact with Cirqle Biomedical for contraceptive candidate
Jul 28Organon: Some Uncomfortable Questions Ahead Of Q2 Earnings
Jul 18Organon Vs. Viatris: Who Is The Clear Winner?
Jun 20Organon: Maximum Optimism
Apr 28Viatris Vs. Organon: Surprisingly Undervalued, But Which Is The Better Buy?
Feb 19Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$15m | US$1m | US$1b |
| Sep 30 2023 | n/a | n/a | US$585m |
| Jun 30 2023 | n/a | n/a | US$754m |
| Mar 31 2023 | n/a | n/a | US$746m |
| Dec 31 2022 | US$14m | US$1m | US$917m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$1b |
| Dec 31 2021 | US$19m | US$1m | US$1b |
Compensación vs. Mercado: La compensación total de Kevin($USD14.95M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.59M).
Compensación vs. Ingresos: La compensación de Kevin ha sido consistente con los resultados de la empresa en el último año.
CEO
Kevin Ali (63 yo)
2.9yrs
Permanencia
US$14,832,272
Compensación
Mr. Kevin Ali is Chief Executive Officer and Director of Organon & Co. since June 2, 2021. Mr. Ali served as the President of Global Enterprise Portfolio Strategy at Merck & Co., Inc. from 2019 to 2021 and...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 2.9yrs | US$14.83m | 0.049% $ 2.6m | |
| Executive VP & CFO | 2.9yrs | US$5.21m | 0.033% $ 1.7m | |
| Executive VP | 1.3yrs | US$3.19m | 0.011% $ 583.9k | |
| Executive VP & Chief Commercial Officer | 3.3yrs | US$3.84m | 0.018% $ 964.3k | |
| Executive VP and Head of Manufacturing & Supply | 2.9yrs | US$3.74m | 0.015% $ 791.7k | |
| Executive VP & Chief Information Officer | 2.9yrs | sin datos | 0.018% $ 943.3k | |
| Head of Investor Relations | 3.3yrs | sin datos | sin datos | |
| Chief Ethics & Compliance Officer | no data | sin datos | sin datos | |
| Chief Communications Officer | no data | sin datos | sin datos | |
| Chief Business Development Officer | no data | sin datos | sin datos | |
| Executive VP & Chief Human Resources Officer | 2.9yrs | sin datos | 0.011% $ 583.4k | |
| Executive VP & Head of Global Business Services | 2.9yrs | sin datos | 0.0082% $ 428.6k |
2.9yrs
Permanencia media
55yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de OGN se considera experimentado (2.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 2.9yrs | US$14.83m | 0.049% $ 2.6m | |
| Independent Chairman of the Board | 2.9yrs | US$450.00k | sin datos | |
| Independent Director | 2.9yrs | US$335.00k | sin datos | |
| Independent Director | 2.9yrs | US$320.00k | 0.00025% $ 13.1k | |
| Independent Director | 2.9yrs | US$320.00k | sin datos | |
| Independent Director | 2.9yrs | US$330.00k | sin datos | |
| Independent Director | 2.9yrs | US$320.00k | sin datos | |
| Independent Director | 2.9yrs | US$345.00k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$320.00k | sin datos | |
| Independent Director | 2.9yrs | US$320.00k | 0.0012% $ 61.4k | |
| Independent Director | 2.9yrs | US$320.00k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$330.00k | 0% $ 0 |
2.9yrs
Permanencia media
63yo
Promedio de edad
Junta con experiencia: La junta directiva de OGN no se considera experimentada (2.8 años de permanencia promedio), lo que sugiere una nueva junta directiva.